Old drug with a new purpose may offer hope for children with neuroblastoma

Links shared publicly online about this topic.

1,241
total visits

Old drug with a new purpose may offer hope for children with neuroblastoma

A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma. According to researchers at the ...

View full resource at physorg.com

Tags: Cancer, Drug, Healthcare, Clinical Trial, Children's Health

Most Recently Shared on April 14, 2010 at 5:26 pm By:

FightCancer

Old drug with a new purpose may offer hope for children with neuroblastoma http://bit.ly/bmoctL

2 years ago...

Retweet

Favorite

Also Shared By:

PhysOrg Health News

Old drug with a new purpose may offer hope for children with neuroblastoma

physorg.com — “A new Phase I clinical trial sponsored by the Vermont Cancer Center at the University of Vermont and Fletcher Allen Health Care has opened to test the investigational drug DFMO, or alpha-difluoromethylornithine, as a treatment for the pediatric cancer neuroblastoma. According to researchers at the ...” View full resource at physorg.com